All Stories

  1. Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)

    Article • Journal of Clinical Medicine, October 2023, MDPI AG

    Jose Maria Guinea de Castro

  2. Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group

    Article • Infectious Diseases and Therapy, December 2022, Springer Science + Business Media

    Jose Maria Guinea de Castro

  3. Diffuse bone marrow metastases of small cell carcinoma with associated erythrophagocytosis mimicking acute leukaemia

    Article • Hematology Transfusion and Cell Therapy, July 2022, Elsevier

    Jose Maria Guinea de Castro

  4. Velcadito: Low dose of bortezomib with melphalan and prednisone for ≥75‐year‐olds newly diagnosed with multiple myeloma

    Article • European Journal Of Haematology, March 2022, Wiley

    Jose Maria Guinea de Castro

  5. Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain [Corrigendum]

    Article • ClinicoEconomics and Outcomes Research, July 2021, Taylor & Francis

    Jose Maria Guinea de Castro

  6. Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study

    Article • BMC Health Services Research, April 2021, Springer Science + Business Media

    Jose Maria Guinea de Castro

  7. Treatment burden in multiple myeloma according to comorbidity in real life

    Article • Annals of Hematology, March 2021, Springer Science + Business Media

    Jose Maria Guinea de Castro

  8. Primary plasma cell leukaemia presenting with flower‐shaped nuclei

    Article • British Journal of Haematology, February 2021, Wiley

    Jose Maria Guinea de Castro

  9. R‐COMP versus R‐CHOP as first‐line therapy for diffuse large B‐cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group

    Article • Cancer Medicine, January 2021, Wiley

    Jose Maria Guinea de Castro

  10. Faggot cells in therapy‐related acute myeloid leukemia with inv(16)

    Article • Clinical Case Reports, November 2020, Wiley

    Jose Maria Guinea de Castro

  11. Acute Monoblastic Leukemia with Erythrophagocytosis and Absence of KAT6A Rearrangement

    Article • Turkish Journal of Hematology, November 2020, Journal of Clinical Research of Pediatric Endocrinology

    Jose Maria Guinea de Castro

  12. Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group

    Article • Advances in Hematology, August 2019, Hindawi Publishing Corporation

    Dr MARIA TERESA ALVAREZ ROMAN, Fernando Fernández Fuertes, Jose Maria Guinea de Castro

  13. ROLE OF CHLORAMBUCIL IN COMBINATION OR NOT WITH ANTI‐CD20 AS FRONTLINE THERAPY IN CHRONIC LYMPHOCYTIC LEUKEMIA IN "REAL LIFE"

    Article • Hematological Oncology, June 2019, Wiley

    Jose Maria Guinea de Castro

  14. Treatment Burden in Patients with Multiple Myeloma According to Comorbidity

    Article • Blood, November 2018, American Society of Hematology

    Jose Maria Guinea de Castro

  15. R-COMP Vs. R-CHOP As First-Line Treatment for De Novo Diffuse Large B-Cell Lymphoma in Patients Older Than 60 Years: Preliminary Results from a Prospective Randomized Phase 2 Study from the Spanish Group Geltamo

    Article • Blood, December 2016, American Society of Hematology

    Jose Maria Guinea de Castro

  16. Safety and Eficacy of Low Dose- Bortezomib Plus Melphalan/Prednisone (velcadito protocol) in Elderly Patintes Not Eligible to Transplant in Newly Dignosed Multiple Myeloma. Restrospective Study of 26 Patients

    Article • Blood, December 2016, American Society of Hematology

    Jose Maria Guinea de Castro

  17. Safety and Efficacy of Bosutinib in Fourth Line Therapy of Chronic Myeloid Leukemia Patients

    Article • Blood, December 2015, American Society of Hematology

    Jose Maria Guinea de Castro

  18. Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program

    Article • American Journal of Hematology, March 2015, Wiley

    Jose Maria Guinea de Castro

  19. Independencia transfusional en un paciente con anemia refractaria con exceso de blastos tipo 2 refractario a 5-azacitidina tratado con deferasirox y agentes estimuladores de colonias

    Article • Medicina Clínica, January 2014, Elsevier

    Jose Maria Guinea de Castro

  20. Myeloid sarcoma preceding an acute promyelocytic leukaemia with neuromeningeal infiltration

    Article • Annals of Hematology, May 2013, Springer Science + Business Media

    Jose Maria Guinea de Castro

  21. A new modified prophylactic scheme against liposomal cytarabine-induced arachnoiditis in adult patients with lymphoma

    Article • Leukemia & Lymphoma, October 2012, Taylor & Francis

    Jose Maria Guinea de Castro

  22. Comparison of Intensive Chemotherapy, Allogeneic, or Autologous Stem-Cell Transplantation As Postremission Treatment for Children With Very High Risk Acute Lymphoblastic Leukemia: PETHEMA ALL-93 Trial

    Article • Journal of Clinical Oncology, January 2006, American Society of Clinical Oncology (ASCO)

    Dr Albert Oriol, Jose Maria Guinea de Castro